Ana Maria Sandri

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob et al. · Clinical Infectious Diseases · 2013 · 417 citations

Reduction in Inddence of Nosocomial Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA

Ana Maria Sandri, Micheline Gisele Dalarosa, Luciana Ruschel de Alcântara et al. · Infection Control and Hospital Epidemiology · 2006 · 106 citations

Nasal Carrier, Drug Resistance, Hospital Medicine +17

Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis

Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob et al. · Journal of Antimicrobial Chemotherapy · 2012 · 74 citations

Outbreak of Carbapenem-Resistant <i>Providencia stuartii</i> in an Intensive Care Unit

Alexandre Prehn Zavascki, Cecília G Carvalhaes, Geórgia L. da Silva et al. · Infection Control and Hospital Epidemiology · 2012 · 38 citations

Bacterial Resistance, Medical Microbiology, Antimicrobial Susceptibility +15

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients

Patrick O. Hanafin, Roger L. Nation, Marc H. Scheetz et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 31 citations · Full text